EXAS Latest Headlines

Exact Sciences Sets February 20, 2026 Virtual Meeting for Shareholder Vote on $105-per-Share Abbott Merger

at www.tipranks.com (Fri, 9-Jan 8:50 AM)

EXAS Faces Shareholder Scrutiny Over Abbott Buyout—Is the $105 Cash Offer Truly Fair?

Market Chameleon (Thu, 20-Nov 9:55 AM)

Abbott’s $21 Billion Acquisition of Exact Sciences Signals New Era in Cancer Diagnostics

Market Chameleon (Thu, 20-Nov 8:00 AM)

EXAS Posts Record Revenue, Expands Outlook, and Launches Pioneering Cancer Test—Margin and Cash Flow Performance Stand Out

Market Chameleon (Tue, 4-Nov 11:22 AM)

Exact Sciences Highlights Multi-Cancer Portfolio Ahead of Jefferies Conference Appearance

Market Chameleon (Tue, 4-Nov 7:07 AM)